Bio-AI Health

Goffstown, United States Founded: 2020 • Age: 6 yrs
AI-based disease diagnosis is provided for healthcare professionals.
Request Access

About Bio-AI Health

Bio-AI Health is a company based in Goffstown (United States) founded in 2020 by Alan Jerusalmi and Thomas Colarusso.. Bio-AI Health has raised $3.5 million across 2 funding rounds. Bio-AI Health offers products and services including AI Biomarker Services, PredictX Platform, and Data Sourcing Services. Bio-AI Health operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.

  • Headquarter Goffstown, United States
  • Founders Alan Jerusalmi, Thomas Colarusso
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bioai Health Inc
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.5 M (USD)

    in 2 rounds

  • Latest Funding Round
    $500 K (USD), Seed

    Apr 05, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Bio-AI Health

Bio-AI Health offers a comprehensive portfolio of products and services, including AI Biomarker Services, PredictX Platform, and Data Sourcing Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Identifies genetic mutations in images for rapid patient screening.

Enables causal AI for disease biology and drug target identification.

Provides access to biospecimen and clinical data for research needs.

People of Bio-AI Health
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Tom Chittenden, PhD, DPhil, PStat
Chief Scientific Officer
People
Krishna Bairavi Soundararajan
Lead AI Scientist
People
Alan Jerusalmi, PhD
Chief Innovation Officer & Co-founder
People
Thomas Colarusso
CEO, President & Co-Founder

Unlock access to complete

Funding Insights of Bio-AI Health

Bio-AI Health has successfully raised a total of $3.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $500,000
  • First Round

    (31 May 2022)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2024 Amount Seed - Bio-AI Health Valuation

investors

May, 2022 Amount Seed - Bio-AI Health Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Bio-AI Health

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Bio-AI Health

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bio-Ai Health Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Bio-AI Health

Bio-AI Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
domain founded_year HQ Location
AI and cloud-powered software for stroke care coordination is developed.
domain founded_year HQ Location
AI-powered single cell classification and isolation technology for clinical research
domain founded_year HQ Location
Digital pathology software is developed for clinical and veterinary productivity.
domain founded_year HQ Location
AI-based pathology diagnostic software is provided for medical analysis.
domain founded_year HQ Location
AI-based tools for pathological image analysis are provided to labs.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Bio-AI Health

When was Bio-AI Health founded?

Bio-AI Health was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is Bio-AI Health located?

Bio-AI Health is headquartered in Goffstown, United States. It is registered at Goffstown, New Hampshire, United States.

Who is the current CEO of Bio-AI Health?

Thomas Colarusso is the current CEO of Bio-AI Health. They have also founded this company.

Is Bio-AI Health a funded company?

Bio-AI Health is a funded company, having raised a total of $3.5M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on May 31, 2022.

What does Bio-AI Health do?

Bio-AI Health was founded in 2020 in Goffstown, United States, within the healthcare and AI sector. Software is developed by the company to support precision medicine and patient profiling. Features for pathology analysis and multi-omic data processing are included in the diagnosis tool. Assistance is offered to healthcare professionals through these integrated capabilities.

Who are the top competitors of Bio-AI Health?

Bio-AI Health's top competitors include Aignostics, Deciphex and Pictor Labs.

What products or services does Bio-AI Health offer?

Bio-AI Health offers AI Biomarker Services, PredictX Platform, and Data Sourcing Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available